# Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

> **NCT00178607** · — · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 99 (actual)

## Conditions studied

- Hemophilia A

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00178607
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2016-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00178607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00178607, "Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00178607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
